Onyx Pharmaceuticals deal

Onyx will receive an undisclosed upfront research fee and an equity investment, as well as milestones and royalties. Warner-Lambert's Parke-Davis subsidiary receives exclusive worldwide marketing rights excluding Japan to all products from the collaboration. Onyx said payments prior to commercialization could total $25 million. ...